Michael S. Gordon, M.D.

Michael S. Gordon, M.D. serves as President and CEO of Pinnacle Oncology Hematology, Associate Director of Clinical Research for the Arizona Cancer Center and as Associate Professor of Clinical Medicine at the University of Arizona College of Medicine.

Dr. Gordon’s research interest is the development of new anticancer agents and applying those agents to clinical trials. He has been recognized for his work in new drug discovery, most notably biologic therapy and anti-angiogenic drugs (drugs that block new blood vessel growth to starve tumors).

Dr. Gordon’s disease-related foci include melanoma, renal cell cancer and ovarian cancer.